Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match

This publication has 8 references indexed in Scilit:

• PLASMAPHERESIS AND INTRAVENOUS IMMUNE GLOBULIN PROVIDES EFFECTIVE RESCUE THERAPY FOR REFRACTORY HUMORAL REJECTION AND ALLOWS KIDNEYS TO BE SUCCESSFULLY TRANSPLANTED INTO CROSS-MATCH-POSITIVE RECIPIENTS
  Transplantation, 2000
• FLOW CROSS-MATCHING IDENTIFIES PATIENTS AT RISK FOR POSTOPERATIVE ELABORATION OF CYTOTOXIC ANTIBODIES
  Transplantation, 1998
• Prevention of hyperacute rejection by removal of antibodies to HLA immediately before renal transplantation
  The Lancet, 1996
• Kidney transplantation in highly sensitized patients: reappraisal of etiology, evaluation, and management protocols
  World Journal of Urology, 1996
• SUPPRESSION OF HLA-SPECIFIC ALLOANTIBODIES BY HIGH-DOSE INTRAVENOUS IMMUNOGLOBULINS (IVIg)
  Transplantation, 1993
• PROGNOSTIC INDICES TO PREDICT SURVIVAL OF FIRST AND SECOND RENAL ALLOGRAFTS
  Transplantation, 1991
• Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies.
  Proceedings of the National Academy of Sciences, 1987
• RENAL TRANSPLANTATION AFTER REMOVAL AND PREVENTION OF RESYNTHESIS OF HLA ANTIBODIES
  The Lancet, 1984